This is in contrast to the HER2/neu- cell lines where we observed no significant reduction in tumor cell survival in anti-HER2/neu antibody-treated cells and no enhancement of tumor cell growth reduction beyond the α-TEA-mediated effect (Figure 2C and 2D). This evidence concerns the gene ERBB2 and neoplasm.